Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KÄÄPÄ Biotech is a Finnish biotechnology company specializing in the research, cultivation, and processing of medicinal mushrooms. The company operates one of the largest indoor mushroom cultivation facilities in Europe and utilizes advanced Ultrasonic Assisted Extraction (UAE) technology to produce high-potency fungal extracts. Their business model spans the entire value chain, from forest management and sustainable wild harvesting to laboratory research and large-scale manufacturing. KÄÄPÄ Biotech provides raw materials for the nutraceutical and food industries while also offering consumer-facing products through its KÄÄPÄ Health brand. The company is recognized for its commitment to transparency, sustainability, and scientific rigor in the functional fungi market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KÄÄPÄ Biotech.